Expertise in
12
conditions

Vito G. Di Lernia

Reggio Nell'emilia, IT 
Expertise in
12
conditions
Reggio Nell'emilia, IT 
OverviewLocationsClinical Research

Overview

Vito Di Lernia practices in Reggio Nell'emilia, Italy. Di Lernia is highly rated in 12 conditions, according to our data. Their top areas of expertise are Psoriasis, Plaque Psoriasis, Pityriasis Lichenoides, and Pityriasis Lichenoides Et Varioliformis Acuta.

Their clinical research consists of co-authoring 128 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Locations

Reggio Nell'emilia, Italy
Other Locations
Bologna, Italy
Pisa, Italy
Ravenna, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Safety and Efficacy of Baricitinib in Combination With Topical Corticosteroids in Adult Patients With Moderate-to-Severe Atopic Dermatitis Who Have Experienced Failure to Cyclosporine or Are Intolerant to, or Have Contraindication to, Cyclosporine
A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Safety and Efficacy of Baricitinib in Combination With Topical Corticosteroids in Adult Patients With Moderate-to-Severe Atopic Dermatitis Who Have Experienced Failure to Cyclosporine or Are Intolerant to, or Have Contraindication to, Cyclosporine
Enrollment Status: Completed
Publish Date: May 14, 2024
Intervention Type: Drug
Study Drugs: Baricitinib, Corticosteroid
Study Phase: Phase 3

128 Total Publications

Switching to brodalumab after failure of IL-17A inhibitors in psoriatic patients: A real-life multicentre study.
Switching to brodalumab after failure of IL-17A inhibitors in psoriatic patients: A real-life multicentre study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: April 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Di Lernia's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 40 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile